ACS Systems Improving Delivery of Healthcare in Malta

iSOFTAffiliated Computer Services, Inc. announced that it has successfully completed Phase I of the Government of Malta's Integrated Health Information System (IHIS), program to attain the highest quality patient care for the citizens of Malta.

Along with iSOFT, a key technology partner, ACS has installed state-of-the-art IT infrastructure that connects laboratory, radiology, and image archiving communication systems and integrates them with iSOFT's Patient Administration System and Clinical Order Communication and Results Reporting System. The systems have already helped improve the delivery and management of healthcare service and records in Malta's new 850-bed Mater Dei Hospital, the nation's largest healthcare facility. ACS will also provide ongoing operations, maintenance, and integration services and support through an on-site command center.

"The rapid implementation of this system was designed to provide quick benefits to the citizens of Malta," said Charles Bracken, managing director of ACS Healthcare Solutions. "Not only were we required to install new digital technology, but laboratory and radiology services had to be completely updated in the process, and all of this needed to happen while Mater Dei Hospital was moving to a new campus."

"By developing and deploying important IT partnerships, we were able to meet our aggressive deadlines. We transferred our healthcare knowledge to the Government of Malta in record time. Now we look forward to leveraging our global healthcare experience and expertise to help Mater Dei Hospital provide world-class care to those who need it most," he said.

Mater Dei's 150 laboratory scientists conduct 4.5 million tests each year for healthcare professionals throughout Malta. Replacing largely manual processes, iSOFT's i.Laboratory systems will speed the turnaround of test results, increase the accuracy of test data and patient information, enhance the legibility of critical reports, and provide better access to patient demographics and specimen records, all improving the quality and efficiency of healthcare delivery.

"Meticulous planning and great team work with ACS enabled us to meet an urgent customer need," said Paul Richards, managing director of iSOFT in the United Kingdom and Ireland. "This implementation took less than five months to complete, which is a considerable achievement for a project of this scale and complexity."

i.Laboratory also allows tests, samples, and results to be tracked across all of the hospital's laboratories, including chemistry, haematology, immunology, microbiology, virology, toxicology, pathology, and cytology. Ultimately every ward within Mater Dei will be able to order tests and view the results online.

Related news articles:

About iSOFT
iSOFT is an IBA Health Group company.

IBA Health Group Limited is the largest specialist information technology company listed on the Australian Securities Exchange. Today, over 13,000 provider organisations in 35 countries across five continents use IBA's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of our market, and anticipation of evolving requirements. Its business is driven by the collective talent, experience, and commitment of over 3,500 healthcare IT experts around the globe. A global network of IBA subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result IBA offers its customers comprehensive knowledge of local market requirements, in terms of culture, language, working practice, healthcare regulation, and organisational structure.

About ACS
ACS, a global FORTUNE 500 company with 62,000 people supporting client operations reaching more than 100 countries, provides business process outsourcing and information technology solutions to world-class commercial and government clients. The company's Class A common stock trades on the New York Stock Exchange under the symbol "ACS". Learn more about ACS at www.acs-inc.com.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...